<\/span><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"Pubblichiamo la comunicazione di Alisa prot. 15464 riguardante Sospensione AIC medicinali contenenti “17 alfa idrossiprogesterone caproato”<\/p>\n","protected":false},"author":563,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,144],"tags":[],"class_list":["post-6057","post","type-post","status-publish","format-standard","hentry","category-news-dell-ordine","category-news1"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/6057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/users\/563"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/comments?post=6057"}],"version-history":[{"count":0,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/6057\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/media?parent=6057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/categories?post=6057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/tags?post=6057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![](\"https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png\")
ALISA – Prot. n. 15464 – del 08\/08\/2024 – Trasmissione provvedimento AIFA – Sospensione AIC medicinali contenenti “17 alfa idrossiprogesterone caproato”"},"content":{"rendered":"![]("https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png")
<\/span>